Kinnari Patel
President chez ROCKET PHARMACEUTICALS, INC.
Fortune : 10 M $ au 31/03/2024
Profil
Kinnari Patel's current job is as the President, Chief Operating Officer, and Head of R&D at Rocket Pharmaceuticals, Inc. He started this position in 2024.
Dr. Patel's former jobs include being the Head of US Risk Management at Bristol Myers Squibb Co. from 2010 to 2014, and the Chief Operating Officer & Head of Development at Rocket Pharmaceuticals Ltd.
from 2016 to 2021.
Dr. Patel's education history includes an undergraduate and doctorate degree from the University of the Sciences in Philadelphia, as well as an MBA from The Leonard N Stern School of Business.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
16/02/2024 | 378 903 ( 0,42% ) | 10 M $ | 31/03/2024 |
Postes actifs de Kinnari Patel
Sociétés | Poste | Début |
---|---|---|
ROCKET PHARMACEUTICALS, INC. | President | - |
Anciens postes connus de Kinnari Patel
Sociétés | Poste | Fin |
---|---|---|
Rocket Pharmaceuticals Ltd.
Rocket Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Rocket Pharmaceuticals Ltd. operates as a biotechnology company which focuses on developing gene therapy treatment for undertreated diseases. The firm’s pipeline includes Fanconi Anemia, Pyruvate Kinase Deficiency, Leukocyte Adhesion Deficiency-1 and Infantile Malignant Osteopetrosis. It also develops an AAV-based therapy program for an undisclosed rare pediatric disease. The company is headquartered in New York, NY. | Chief Operating Officer | 01/02/2021 |
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/04/2014 |
Formation de Kinnari Patel
University of the Sciences in Philadelphia | Doctorate Degree |
The Leonard N Stern School of Business | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
ROCKET PHARMACEUTICALS, INC. | Health Technology |
Entreprise privées | 1 |
---|---|
Rocket Pharmaceuticals Ltd.
Rocket Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Rocket Pharmaceuticals Ltd. operates as a biotechnology company which focuses on developing gene therapy treatment for undertreated diseases. The firm’s pipeline includes Fanconi Anemia, Pyruvate Kinase Deficiency, Leukocyte Adhesion Deficiency-1 and Infantile Malignant Osteopetrosis. It also develops an AAV-based therapy program for an undisclosed rare pediatric disease. The company is headquartered in New York, NY. | Health Technology |